Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

AstraZeneca invests $2bn in Summit to accelerate ivonescimab development

AstraZeneca will invest $2bn in Summit Therapeutics to accelerate the development of ivonescimab and expand its potential use in combination with ADCs. The companies will also collaborate on trials combining..

September 29, 2026

Genflow completes SLAB trial as human and animal health programmes advance

Genflow Biosciences completed its SLAB canine healthspan and sarcopenia trial in H1 2026, with the company reporting safety and tolerability data for GF-1004. The group also advanced its glaucoma, MASH,..

September 29, 2026

Turning breakthrough science into commercial opportunity

Breakthrough science creates commercial opportunity when capital, execution and persistence turn early innovation into scalable technology...

September 28, 2026

Physitrack launches AI-powered EMR in the US

Physitrack has launched its own electronic medical record for US physical therapy and rehabilitation practices, expanding its offering into clinical workflow management with paid subscriptions planned from January 2027...

September 28, 2026

Halma raises profit margin guidance after strong first half

Halma expects a 23.5%–24% Adjusted EBIT margin for 2027 after strong first-half growth and £515m of acquisitions...

September 24, 2026

CVS reports 5.9% revenue growth as Australia expansion continues

CVS delivered 5.9% revenue growth to £712.8m in FY26, while adjusted EBITDA rose 5.1% to £141.5m. Australian revenue increased 52% to £79.1m as the veterinary group expanded its practice network...

September 24, 2026

Cizzle Bio pushes blood test into lung cancer screening

Cizzle Bio is developing a blood test designed to add biomarker information to existing lung cancer screening...

September 23, 2026

The Biotech Growth Trust plc – Why Biotech’s Recovery Could Still Have Further to Run (video)

Biotech valuations have rebounded, pharmaceutical M&A has accelerated and regulatory uncertainty has begun to ease — but Josh Golomb of The Biotech Growth Trust believes the more important story is..

September 23, 2026

AstraZeneca’s Trixeo Aerosphere approved in EU for asthma

The European Commission has approved AstraZeneca’s Trixeo Aerosphere as a maintenance treatment for patients aged 12 and older whose asthma is inadequately controlled with medium-dose ICS/LABA therapy...

September 23, 2026

Age-related disease keeps biotechnology research in focus

Age-related conditions such as glaucoma and sarcopenia continue to support interest in biotechnology research focused on the biology of ageing...

September 22, 2026

Oxford Biomedica reports 9% revenue growth as new client wins accelerate

Oxford Biomedica reported H1 2026 revenue of £79.8 million, up 9% year on year, alongside record new client wins and improved adjusted EBITDA. The company reiterated its FY 2026 guidance..

September 22, 2026

Biotechnology innovation is expanding the commercial opportunity

New therapies, AI and precision drug delivery are expanding the commercial potential of biotechnology...

September 21, 2026

AstraZeneca’s Klygefa recommended for EU approval in generalised myasthenia gravis

The EMA’s CHMP has recommended Klygefa (gefurulimab) for approval as an add-on treatment for adults with AChR antibody-positive generalised myasthenia gravis, based on Phase III PREVAIL trial results...

September 21, 2026

Verici Dx expands diagnostics portfolio with Q4 launch of TranscripTx

Verici Dx plans to launch TranscripTx in Q4 2026, adding a transplant-focused multi-gene test to its commercial portfolio. The product leverages the company’s RNA diagnostics expertise, clinical data repository and..

September 21, 2026

Physitrack expands its role in physical therapy software workflows

Physitrack is building its role as a digital rehabilitation layer that works alongside the EMR systems already used by physical therapy practices...

September 18, 2026

Verici Dx offers three-test platform for kidney transplant risk assessment

Verici Dx has built a three-test kidney transplant platform covering pre-transplant rejection risk, post-transplant acute rejection and progressive fibrosis...

September 17, 2026

EDX Medical signs three-year employee health screening deal with Arnold Clark Group

EDX Medical has entered a three-year agreement to provide health and wellbeing screening to Arnold Clark Group employees across the UK, with the contract expected to generate annual revenue of..

September 17, 2026

Oxford Nanopore wins preliminary injunction against MGI Tech

The Munich Local Division of the Unified Patent Court has granted Oxford Nanopore a preliminary injunction restricting sales and use of MGI Tech’s Cyclone Sequencing Systems across several European markets...

September 16, 2026

Physitrack clarifies its role alongside physical therapy billing software

Physitrack is positioning its platform alongside physical therapy billing software, focusing on patient engagement, rehabilitation workflows and system integration...

September 15, 2026

GSK to acquire Chimagen Trispecific T-cell engager for multiple myeloma

GSK has agreed to acquire global rights to Chimagen Biosciences’ trispecific T-cell engager for multiple myeloma in a deal worth up to $750 million. The programme is expected to enter..

September 15, 2026

News and Interview Alerts

Company Presentations

Time Finance Profits Surge, Book Grows 86% as New Strategy Targets £300m Lending

Q&As

Biotech Growth Trust Portfolio Manager on valuations, M&A and sector recovery

30 September 2026

CMC Markets MD Chris Cheverall on 24/7 market access, CMC Connect and AI opportunities

30 September 2026

Premier Miton UK Multi Cap Income Fund: The case for UK income and small-cap stocks

24 September 2026

Personal Group praised by Fund Manager for income growth and market share gains

23 September 2026

ACG Metals ‘substantial cash flow’ potential highlighted by Gervais Williams

23 September 2026

Hardman & Co

ICG Enterprise Trust: Investor questions answered and 1HFY’27 results

14 October 2026

Neuberger Private Equity Partners Limited 1H’26 results: Foot on the accelerator

8 October 2026

Chesnara Plc: Acquisitions show immediate benefits

2 September 2026

Arbuthnot Banking Group Plc 1H’26: accelerating franchise growth

4 August 2026

Real Estate Credit Investments maintains dividend as credit remains resilient

3 August 2026

Green News

Ferro-Alloy Resources appoints Peter Secker as CEO

26 October 2026

Ilika launches ORKA brand for deep-sea battery systems

22 October 2026

Drax Group Shares Offer Significant Valuation Upside as Data Centre Opportunity Remains Intact, Says Longspur Research

13 October 2026

Ampeak Energy Director Buys 500,000 shares in market purchase

6 October 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

The Biotech Growth Trust plc – Why Biotech’s Recovery Could Still Have Further to Run (video)

CMC Markets Chris Cheverall Explains Why 24/7 Liquidity and AI Could Reshape CMC Connect (video)

Touchstone Exploration: Paul Baay targets new production as Cascadura optimisation gathers momentum (video)

Premier Miton UK Multi Cap Income Fund: Gervais Williams on the overlooked UK income stocks (video)

Ilika plc: Goliath gains commercial momentum as validation, defence interest and Brompton trials converge (video)

Cora Gold: Standout Zone B grades point to a bigger Sanankoro mine plan (video)

BrokerTalk

Cora Gold moves closer to construction readiness at Sanankoro as funding risk recedes, Cavendish

5 September 2026

Valeura Energy accelerates Wassana first oil as 2027 production outlook improves, Auctus Advisors

4 September 2026

Physitrack Q2 2026 Shows ARR Growth, RTM Launch and Wellness Profit Recovery, Redeye

2 September 2026

Cora Gold sees strong bank appetite for US$60m Sanankoro debt financing, Cavendish

1 September 2026

Diversified Energy adds operated drilling to growth playbook, Tennyson Securities

1 September 2026

Funds

Real Estate Credit Investments reports 10.5% dividend yield and £5m Spanish loan commitment

28 October 2026

City Natural Resources Growth and Income PLC

City Natural Resources Growth and Income reports 76.6% annual NAV return

28 October 2026

Volta Finance generates €38m in interest income with 1.8x dividend cover

22 October 2026

Geiger Counter highlights strong uranium market fundamentals and growing nuclear demand

21 October 2026

City Natural Resources Chairman Christopher Casey outlines Tufton’s investment strategy

21 October 2026

View all Funds, Market Insights and news >>

FTSE 100 News

Rio Tinto to invest $1.9 billion in Queensland bauxite project

23 October 2026

Barclays reports 12% profit growth, announces £500m share buyback

22 October 2026

LSEG raises 2026 guidance after 8.8% Q3 income growth

22 October 2026

RELX reports 7% underlying revenue growth and reaffirms full-year outlook

22 October 2026

UK Broker Ratings

Cranswick PLC (CWK.L) Stock Analysis: Evaluating a 20.73% Upside Potential in Packaged Foods

28 October 2026

Coats Group PLC (COA.L) Stock Analysis: Strong Buy Ratings and 45% Potential Upside

28 October 2026

Bellway PLC (BWY.L): An Investor’s Insight into Growth Potential with a 21% Revenue Surge

28 October 2026

Chemring Group PLC (CHG.L) Investor Outlook: Exploring a 14.74% Potential Upside in the Aerospace & Defense Sector

28 October 2026

Close Brothers Group PLC (CBG.L): Analyst Ratings Signal a 34.63% Potential Upside

28 October 2026

Health

AstraZeneca invests $2bn in Summit to accelerate ivonescimab development

September 29, 2026

Genflow completes SLAB trial as human and animal health programmes advance

September 29, 2026

Turning breakthrough science into commercial opportunity

Breakthrough science creates commercial opportunity when capital, execution and persistence turn early innovation into scalable technology...

September 28, 2026

Physitrack launches AI-powered EMR in the US

September 28, 2026

Halma raises profit margin guidance after strong first half

Halma expects a 23.5%–24% Adjusted EBIT margin for 2027 after strong first-half growth and £515m of acquisitions...

September 24, 2026

CVS reports 5.9% revenue growth as Australia expansion continues

September 24, 2026

Cizzle Bio pushes blood test into lung cancer screening

Cizzle Bio is developing a blood test designed to add biomarker information to existing lung cancer screening...

September 23, 2026

The Biotech Growth Trust plc – Why Biotech’s Recovery Could Still Have Further to Run (video)

September 23, 2026

AstraZeneca’s Trixeo Aerosphere approved in EU for asthma

September 23, 2026

Age-related disease keeps biotechnology research in focus

Age-related conditions such as glaucoma and sarcopenia continue to support interest in biotechnology research focused on the biology of ageing...

September 22, 2026

Oxford Biomedica reports 9% revenue growth as new client wins accelerate

Oxford Biomedica reported H1 2026 revenue of £79.8 million, up 9% year on year, alongside record new client wins and improved adjusted EBITDA. The company reiterated its FY 2026 guidance and said its Durham, North Carolina GMP manufacturing facility is now operational...

September 22, 2026

Biotechnology innovation is expanding the commercial opportunity

New therapies, AI and precision drug delivery are expanding the commercial potential of biotechnology...

September 21, 2026

AstraZeneca’s Klygefa recommended for EU approval in generalised myasthenia gravis

September 21, 2026

Verici Dx expands diagnostics portfolio with Q4 launch of TranscripTx

September 21, 2026

Physitrack expands its role in physical therapy software workflows

Physitrack is building its role as a digital rehabilitation layer that works alongside the EMR systems already used by physical therapy practices...

September 18, 2026

Verici Dx offers three-test platform for kidney transplant risk assessment

Verici Dx has built a three-test kidney transplant platform covering pre-transplant rejection risk, post-transplant acute rejection and progressive fibrosis...

September 17, 2026

EDX Medical signs three-year employee health screening deal with Arnold Clark Group

EDX Medical has entered a three-year agreement to provide health and wellbeing screening to Arnold Clark Group employees across the UK, with the contract expected to generate annual revenue of £1.4 million to £1.6 million...

September 17, 2026

Oxford Nanopore wins preliminary injunction against MGI Tech

September 16, 2026

Physitrack clarifies its role alongside physical therapy billing software

Physitrack is positioning its platform alongside physical therapy billing software, focusing on patient engagement, rehabilitation workflows and system integration...

September 15, 2026

GSK to acquire Chimagen Trispecific T-cell engager for multiple myeloma

GSK has agreed to acquire global rights to Chimagen Biosciences’ trispecific T-cell engager for multiple myeloma in a deal worth up to $750 million. The programme is expected to enter Phase I trials in 2027...

September 15, 2026